CD19 and systemic sclerosis: A deficiency of the CD19 gene leads to diminished skin thickening and lung fibrosis in the Bleomycin (BLM)-induced SSc mouse model when compared to BLM-treated WT littermates, indicating that B cells are actively involved in the fibrotic process that mediates skin and lung disease (15).